GORDON CONFERENCE--FIBRONECTIN AND MACROMOLECULES
GORDON CONFERENCE--FIBRONECTIN AND MACROMOLECULES
批准号:
3435740
负责人:
Mark HOWARD Ginsberg
金额:
$1.2万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-02-01 至 1994-01-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The paradigm of an extracellular adhesin, fibronectin, interacting with a
transmembrane receptor has proven applicable to a number of adhesion
systems. There are several other extracellular glycoproteins with
biological properties like fibronectin, laminin, thrombospondin, von
Willebrand factor, fibrinogen/fibrin, vitronectin, and
cytotactin/tenascin/hexabrachion. The primary structures of each of
these proteins are determined and three-dimensional structures are in
progress for some. This will open up new possibilities for studies of
function. In parallel has come the realization that the transmembrane
receptor for fibronectin is only one member of the integrin family of
functionally related, homologous, cell adhesion receptors. Fibronectin
and related macromolecules are involved in many basic functions of cells,
including cell adhesion, determination of cell shape and differentiation,
cell migration, cytoskeletal organization, and organization of
extracellular matrix. Thus, fibronectin and the molecules with which it
interacts are important in embryogenesis, connective tissue organization,
hemostasis, thrombosis, wound healing, development of immunity,
hematopoiesis, malignant transformation, and tumor metastasis. The
challenges to the field over the next several years are to comprehend and
organize the large amount of new structural information and design
experiments based upon it; learn the relative biological importance of
the several seemingly redundant adhesion systems; and apply the new
insights to the treatment of human diseases. The 1993 Gordon Research
Conference will serve as a valuable forum to present and discuss new
information, identify problem areas, and plan new approaches.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cellular Mechanisms of Inflammation, Hemostasis, and Thrombosis
-
批准号:10229365
-
项目类别:
-
资助金额:$234.03万
-
财政年份:2020
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Cellular Mechanisms of Inflammation, Hemostasis, and Thrombosis
-
批准号:10676869
-
项目类别:
-
资助金额:$233.35万
-
财政年份:2020
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Direct Rap1-talin interaction in platelets, leukocytes, and endothelial cells
-
批准号:10229368
-
项目类别:
-
资助金额:$48.79万
-
财政年份:2020
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Core B - Ginsberg-ADMINISTRATIVE CORE
-
批准号:10676887
-
项目类别:
-
资助金额:$7.86万
-
财政年份:2020
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Core B - Ginsberg-ADMINISTRATIVE CORE
-
批准号:10229366
-
项目类别:
-
资助金额:$7.95万
-
财政年份:2020
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Direct Rap1-talin interaction in platelets, leukocytes, and endothelial cells
-
批准号:10676892
-
项目类别:
-
资助金额:$48.69万
-
财政年份:2020
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Deconvoluting the Vascular Adhesome
-
批准号:10327637
-
项目类别:
-
资助金额:$78.7万
-
财政年份:2018
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Deconvoluting the Vascular Adhesome
-
批准号:10548841
-
项目类别:
-
资助金额:$78.7万
-
财政年份:2018
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Anti-Coagulant and Cytoprotective activity in CCM pathogenesis
-
批准号:10417155
-
项目类别:
-
资助金额:$31.45万
-
财政年份:2015
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Anti-Coagulant and Cytoprotective activity in CCM pathogenesis
-
批准号:10621253
-
项目类别:
-
资助金额:$31.38万
-
财政年份:2015
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Anti-Coagulant and Cytoprotective activity in CCM pathogenesis
-
批准号:10220146
-
项目类别:
-
资助金额:$31.52万
-
财政年份:2015
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Composition and Functions of the Integrin Activation Complex
-
批准号:8695078
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2014
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Project 4: A Binary Switch in Adhesion Maturation
-
批准号:8234230
-
项目类别:
-
资助金额:$26.99万
-
财政年份:2011
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Administrative Core
-
批准号:8256553
-
项目类别:
-
资助金额:$9.43万
-
财政年份:2011
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
KRIT1 and Vascular Integrity
-
批准号:8038085
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2011
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Activation of B3 Integrins
-
批准号:8256548
-
项目类别:
-
资助金额:$47.35万
-
财政年份:2011
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
KRIT1 and Vascular Integrity
-
批准号:8207881
-
项目类别:
-
资助金额:$38.69万
-
财政年份:2011
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
KRIT1 and Vascular Integrity
-
批准号:8605067
-
项目类别:
-
资助金额:$37.98万
-
财政年份:2011
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
KRIT1 and Vascular Integrity
-
批准号:8402853
-
项目类别:
-
资助金额:$36.89万
-
财政年份:2011
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
Activation of B3 Integrins
-
批准号:7995808
-
项目类别:
-
资助金额:$47.89万
-
财政年份:2010
-
负责人:Mark HOWARD Ginsberg
-
依托单位:
海外基金